Prior studies have identified a tumor-suppressive role of NFKBIA in Hodgkin’s lymphoma (Cabannes et al., 1999), colorectal cancer (Gao et al., 2007), and hepatocellular carcinoma (He et al., 2009) for specific single nucleotide polymorphisms and haplotypes of NFKBIA (Shen et al., 2015). The gene discussed is NFKBIA; the disease is hepatocellular carcinoma.